Showing results (21-30 of 109) with videos related to

Sort By:
Pageof 11
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|March 31, 2022
Risk factors for opioid-induced constipation in cancer patients: a single-institution, retrospective analysisYuko Kanbayashi, Yuichi Ishizuka, Mayumi Shimizu, et al.
Frontiers in Pharmacology|July 17, 2023
Multicenter prospective observational study on hospital pharmacist interventions to reduce inappropriate medicationsShinya Suzuki, Mayako Uchida, Hideki Sugawara, et al.
The Oncologist|September 23, 2025
Adverse events of antibody-drug conjugates: comparative analysis of agents with a common payload using the adverse event spontaneous reporting databaseKenta Yamaoka, Sho Masago, Mayako Uchida, et al.
Oncology|June 6, 2023
Adverse Event Profile of Azacitidine: Analysis by Route of Administration Using Japanese Pharmacovigilance DatabaseKenta Yamaoka, Masaki Fujiwara, Mayako Uchida, et al.
In Vivo (Athens, Greece)|February 27, 2026
Cardiovascular Adverse Events Associated With Carfilzomib, Bortezomib, and Ixazomib: A Disproportionality Analysis Using the Japanese Adverse Drug Event Report Database With Anticancer Agents as the Reference GroupMasaki Fujiwara, Shuji Nagano, Yoshihiro Uesawa, et al.
International Journal of Hematology|April 15, 2026
Impact of lymphocyte p-glycoprotein activity on development of graft-versus-host disease after stem cell transplantationShoji Nakamura, Soichiro Tajima, Takeshi Hirota, et al.
Die Pharmazie|April 30, 2026
Efficacy and Safety of Prophylactic Opioid Rescue for Breakthrough Pain Due to Body Movement: A Multicenter Retrospective StudyRyo Taguchi, Rei Tanaka, Eiji Kose, et al.
In Vivo (Athens, Greece)|June 30, 2026
Adverse Event Profiling and Comparative Analysis of HER2-targeting Antibody-drug Conjugates Using Pharmacovigilance DatabasesKousuke Hosonaka, Kenta Yamaoka, Mayako Uchida, et al.
Plos One|December 9, 2022
Factors associated with non-response to naldemedine for opioid-induced constipation in cancer patients: A subgroup analysisYuko Kanbayashi, Mayumi Shimizu, Yuichi Ishizuka, et al.
Oncology|May 3, 2022
Comprehensive Analysis of Ixazomib-Induced Adverse Events Using the Japanese Pharmacovigilance DatabaseKenta Yamaoka, Masaki Fujiwara, Mayako Uchida, et al.
Pageof 11